Datwyler QC 600

Datwyler: Elastomers for tomorrow’s healthcare market

With the increasing demands for highly sensitive drugs such as biologics and biosimilars, the requirements , pharmaceuticals and medical product manufacturers are need elastomer components that not only mitigate risks related to drug stability and compatibility, but also provide low particle levels. Here, Datwyler reports on how it is adapting its capabilities and offerings to meet these new industry requirements:

Altdorf, Switzerland - Set against the background of an increasing demand for highly sensitive drugs such as biologics and biosimilars, the requirements for parenteral

To read more,please login or register below.

Login
Log in here using the Email Address
and Password you signed up with